articleTop 1% cited

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

Acta Neuropathologica · 2014 · Vol. 128(5) · pp. 639–650

Min Shi✉(University of Washington)Changqin LiuTravis J. Cook(University of Washington)Kristin M. Bullock(University of Puget Sound)Yanchun Zhao(University of Washington)Carmen Ginghină(University of Washington)Yanfei Li(University of Washington)Patrick Aro(University of Washington)Romel Dator(University of Washington)Chunmei HeMichael J. Hipp(University of Washington)Cyrus P. Zabetian(University of Washington)Elaine R. Peskind(Seattle University)Shu-Ching Hu(VA Puget Sound Health Care System)Joseph F. Quinn(Oregon Health & Science University)Douglas Galasko(University of California, San Diego)William A. Banks(University of Washington)Jing Zhang(Oregon Health & Science University)

View via DOI Publisher page

Parkinson's Disease Mechanisms and Treatments Conducting polymers and applications Transcranial Magnetic Stimulation StudiesBiomarkerCerebrospinal fluidMicrovesiclesParkinson's diseaseAlpha-synucleinPathogenesisMedicineExosomeCentral nervous systemBlood plasma

MeSH terms

AdultAgedAged, 80 and overAnimalsBrainFemaleHumansMaleMicroscopy, ElectronMiddle AgedParkinson DiseaseROC CurveMass SpectrometryCohort StudiesCase-Control Studies

Citations

664

FWCI

16.90

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles